Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Income from Continuing Operations (2020 - 2025)

Historic Income from Continuing Operations for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to -$812541.0.

  • Stemtech's Income from Continuing Operations rose 3063.53% to -$812541.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year increase of 4343.4%. This contributed to the annual value of -$3.8 million for FY2024, which is 3054.65% up from last year.
  • As of Q3 2025, Stemtech's Income from Continuing Operations stood at -$812541.0, which was up 3063.53% from -$296280.0 recorded in Q2 2025.
  • In the past 5 years, Stemtech's Income from Continuing Operations registered a high of $17.4 million during Q3 2022, and its lowest value of -$25.0 million during Q2 2022.
  • Its 5-year average for Income from Continuing Operations is -$1.4 million, with a median of -$812541.0 in 2025.
  • Over the last 5 years, Stemtech's Income from Continuing Operations had its largest YoY gain of 42682.98% in 2022, and its largest YoY loss of 312906.9% in 2022.
  • Stemtech's Income from Continuing Operations (Quarter) stood at -$848155.0 in 2021, then surged by 36.13% to -$541732.0 in 2022, then crashed by 244.08% to -$1.9 million in 2023, then surged by 78.72% to -$396580.0 in 2024, then crashed by 104.89% to -$812541.0 in 2025.
  • Its Income from Continuing Operations was -$812541.0 in Q3 2025, compared to -$296280.0 in Q2 2025 and -$1.5 million in Q1 2025.